Table 1 Patient characteristics
From: Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics
Variables | Total (n = 339) | Low (n = 198) | High (n = 141) | P | Statistic |
|---|---|---|---|---|---|
Age (years), n (%) | 0.344 | 0.894 | |||
~ 59 | 175 (51.62) | 107 (54.04) | 68 (48.23) | ||
60~ | 164 (48.38) | 91 (45.96) | 73 (51.77) | ||
FIGO stage, n (%) | 0.444 | 0.586 | |||
I/II | 19 (5.60) | 9 (4.55) | 10 (7.09) | ||
III/IV | 320 (94.40) | 189 (95.45) | 131 (92.91) | ||
Lymphatic invasion, n (%) | 0.446 | 1.614 | |||
No | 40 (11.80) | 27 (13.64) | 13 (9.22) | ||
Yes | 91 (26.84) | 51 (25.76) | 40 (28.37) | ||
Unknown | 208 (61.36) | 120 (60.60) | 88 (62.41) | ||
Histologic grade, n (%) | 0.852 | 0.035 | |||
G1/G2 | 41 (12.09) | 25 (12.63) | 16 (11.35) | ||
G3/G4/GX | 298 (87.91) | 173 (87.37) | 125 (88.65) | ||
Tumor residual disease, n (%) | 0.033 | 8.713 | |||
No macroscopic disease | 58 (17.11) | 35 (17.68) | 23 (16.31) | ||
1 ~ 10 mm | 162 (47.79) | 103 (52.02) | 59 (41.84) | ||
10 mm~ | 86 (25.37) | 48 (24.24) | 38 (26.95) | ||
Unknown | 33 (9.73) | 12 (6.06) | 21 (14.89) | ||
Venous invasion, n (%) | 0.632 | 0.917 | |||
No | 32 (9.44) | 20 (10.10) | 12 (8.51) | ||
Yes | 59 (17.40) | 37 (18.69) | 22 (15.60) | ||
Unknown | 248 (73.16) | 141 (71.21) | 107 (75.89) | ||
Chemotherapy, n (%) | 0.206 | 1.598 | |||
No | 21 (6.19) | 9 (4.55) | 12 (8.51) | ||
Yes | 318 (93.81) | 189 (95.45) | 129 (91.49) |